PHI with Cerebral thrombosis
How does this condition affect your private health insurance?
Cerebral thrombosis, also known as brain thrombosis, occurs when a blood clot forms in a blood vessel within the brain, blocking vital blood flow. This interruption deprives brain tissue of oxygen and nutrients, leading to an ischemic stroke. Unlike embolic strokes, symptoms often develop gradually over hours or days, including sudden weakness or numbness on one side of the body, difficulty speaking or understanding speech, vision changes, severe headache, dizziness, and loss of balance. Key risk factors include atherosclerosis, high blood pressure, diabetes, high cholesterol, and smoking. Prompt diagnosis and treatment are critical to minimize brain damage and improve patient outcomes.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to weeks for acute care and initial stabilization.
Duration of Illness (Lifetime)
Often chronic, with potential for long-term neurological deficits requiring ongoing management and a risk of recurrence.
Cost of Treatment (Initial)
High (e.g., several tens of thousands to hundreds of thousands of USD for acute hospitalization and treatment).
Cost of Treatment (Lifetime)
Potentially hundreds of thousands to millions of USD over a lifetime, especially with significant disability requiring long-term rehabilitation and care.
Mortality Rate
Moderate to high (e.g., 10-30%, depending on the stroke's severity, location, and timeliness of treatment).
Risk of Secondary Damages
Very high (e.g., 60-80% experience some form of lasting neurological deficit such as paralysis, speech impairment, cognitive issues, or psychological effects).
Probability of Full Recovery
Low to moderate (e.g., 10-30% for near-complete recovery without significant residual symptoms).
Underlying Disease Risk
High probability of underlying conditions like atherosclerosis, hypertension, diabetes, hyperlipidemia, and certain blood clotting disorders.